Group One Trading’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $32.3K | Sell |
10,100
-8,300
| -45% | -$32.1K | ﹤0.01% | 5556 |
|
|
2026
Q2 | $56.1K | Buy |
18,400
+2,100
| +13% | +$8.34K | ﹤0.01% | 5321 |
|
|
2026
Q1 | $73.4K | Buy |
+16,300
| New | +$65.2K | ﹤0.01% | 4975 |
|
|
2025
Q4 | – | Sell |
-500
| Closed | -$1.62K | – | 8733 |
|
|
2025
Q3 | $1.62K | Sell |
500
-3,000
| -86% | -$11.2K | ﹤0.01% | 7960 |
|
|
2025
Q2 | $10.1K | Buy |
3,500
+1,300
| +59% | +$3.01K | ﹤0.01% | 6712 |
|
|
2025
Q1 | $4.73K | Sell |
2,200
-39,100
| -95% | -$124K | ﹤0.01% | 6672 |
|
|
2024
Q4 | $160K | Sell |
41,300
-5,500
| -12% | -$36.3K | ﹤0.01% | 4113 |
|
|
2024
Q3 | $307K | Buy |
+46,800
| New | +$376K | ﹤0.01% | 3245 |
|
|
2024
Q2 | – | Sell |
-37,600
| Closed | -$285K | – | 7160 |
|
|
2024
Q1 | $285K | Buy |
+37,600
| New | +$293K | ﹤0.01% | 3251 |
|
|
2023
Q3 | – | Sell |
-500
| Closed | -$1.56K | – | 8004 |
|
|
2023
Q2 | $1.56K | Buy |
+500
| New | +$2.04K | ﹤0.01% | 7161 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$12K | – | 8571 |
|
|
2021
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 7424 |
|
|
2021
Q2 | $10K | Buy |
+1,000
| New | +$11.3K | ﹤0.01% | 7519 |
|
|
2019
Q3 | – | Sell |
-367
| Closed | -$5K | – | 5369 |
|
|
2019
Q2 | $5K | Hold |
367
| – | – | ﹤0.01% | 4604 |
|
|
2019
Q1 | $12K | Buy |
+367
| New | +$18.8K | ﹤0.01% | 4209 |
|
|
2018
Q3 | – | Sell |
-1,067
| Closed | -$131K | – | 5419 |
|
|
2018
Q2 | $131K | Sell |
1,067
-50
| -4% | -$4.25K | ﹤0.01% | 3377 |
|
|
2018
Q1 | $100K | Buy |
1,117
+1,067
| +2,134% | +$90.4K | ﹤0.01% | 3240 |
|
|
2017
Q4 | $3K | Sell |
50
-117
| -70% | -$5.27K | ﹤0.01% | 4647 |
|
|
2017
Q3 | $7K | Sell |
167
-416
| -71% | -$17.3K | ﹤0.01% | 4389 |
|
|
2017
Q2 | $25K | Buy |
583
+166
| +40% | +$8.49K | ﹤0.01% | 3850 |
|
|
2017
Q1 | $23K | Sell |
417
-10,550
| -96% | -$524K | ﹤0.01% | 3817 |
|
|
2016
Q4 | $418K | Sell |
10,967
-416
| -4% | -$16.9K | ﹤0.01% | 1899 |
|
|
2016
Q3 | $452K | Buy |
11,383
+11,241
| +7,916% | +$511K | ﹤0.01% | 1895 |
|
|
2016
Q2 | $10K | Sell |
142
-1,500
| -91% | -$119K | ﹤0.01% | 4074 |
|
|
2016
Q1 | $132K | Sell |
1,642
-925
| -36% | -$73K | ﹤0.01% | 2627 |
|
|
2015
Q4 | $194K | Buy |
2,567
+1,475
| +135% | +$237K | ﹤0.01% | 2513 |
|
|
2015
Q3 | $419K | Buy |
+1,092
| New | +$492K | 0.01% | 1917 |
|
Other funds holding LRMR
Group One Trading's LRMR Position: Q3 2026 in Review
Group One Trading sold out of Larimar Therapeutics (LRMR) in Q3 2026, closing a stake of 3,596 shares — an estimated $13.9K sold.
Group One Trading first reported a position in LRMR in Q3 2015 and held it in 28 quarters. The position peaked at $432K in Q3 2025. 147 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.
- Group One Trading reported no remaining Larimar Therapeutics position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 3,596 Larimar Therapeutics shares in Q3 2026, an estimated $13.9K.
- Group One Trading first reported a position in Larimar Therapeutics in Q3 2015 and held it in 28 quarters.
- Group One Trading's Larimar Therapeutics position peaked at $432K in Q3 2025.
- 147 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.